patient_id,superpopulation,n_variants_carried,primary_gene,severity_score,severity_category,predicted_progression,all_genes,pathway_Proteostasis,pathway_Proteostasis_score,pathway_Proteostasis_genes,pathway_Proteostasis_mechanisms,pathway_RNA_Metabolism,pathway_RNA_Metabolism_score,pathway_RNA_Metabolism_genes,pathway_RNA_Metabolism_mechanisms,pathway_Cytoskeletal_Axonal_Transport,pathway_Cytoskeletal_Axonal_Transport_score,pathway_Cytoskeletal_Axonal_Transport_genes,pathway_Cytoskeletal_Axonal_Transport_mechanisms,pathway_Mitochondrial,pathway_Mitochondrial_score,pathway_Mitochondrial_genes,pathway_Mitochondrial_mechanisms,pathway_Excitotoxicity,pathway_Excitotoxicity_score,pathway_Excitotoxicity_genes,pathway_Excitotoxicity_mechanisms,pathway_Vesicle_Trafficking,pathway_Vesicle_Trafficking_score,pathway_Vesicle_Trafficking_genes,pathway_Vesicle_Trafficking_mechanisms,pathway_DNA_Damage,pathway_DNA_Damage_score,pathway_DNA_Damage_genes,pathway_DNA_Damage_mechanisms,n_pathways_affected,primary_pathway,all_mechanisms,primary_gene_mechanism
AMR_00000,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_00001,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_00002,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00004,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00005,AMR,2,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_00006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00007,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00009,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00010,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00011,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00012,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00013,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00014,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00015,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00018,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00020,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00021,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00023,AMR,3,TBK1,9.1,Severe,Fast Progression,HNRNPA2B1; SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00024,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00025,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00026,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00027,AMR,1,KIF5A,7.8,Moderate,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_00028,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00029,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00030,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00031,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00032,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00033,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00034,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00035,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00036,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00038,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00039,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00040,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00041,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00042,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00043,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00044,AMR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00045,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00046,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00047,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00048,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00049,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00050,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00051,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00052,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00053,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00054,AMR,3,VCP,7.0,Moderate,Slow Progression,ALS2; LOC130003372; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00056,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00057,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00058,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,SETX: R-loop accumulation; genomic instability | TUBA4A: Microtubule destabilization,R-loop accumulation; genomic instability
AMR_00059,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00060,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00061,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00062,AMR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00063,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00064,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00065,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00066,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00069,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00070,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00071,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00072,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_00073,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00074,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00076,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00077,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00078,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00079,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00080,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00081,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00082,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00083,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00085,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00086,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00087,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00088,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00089,AMR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00090,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00091,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00093,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00094,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00096,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00097,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00098,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00100,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00101,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00102,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00104,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00106,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00107,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00108,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00109,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00110,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00111,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00112,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00113,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00114,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00115,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00116,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00118,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00119,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00120,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00121,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00123,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00124,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00125,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00127,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00128,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00129,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00130,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00131,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00132,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00133,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00134,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00135,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00136,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00139,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00140,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00141,AMR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00142,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00143,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00145,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00146,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00147,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00148,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00149,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00150,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00151,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00153,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00154,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00155,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00156,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00157,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00158,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00160,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00163,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00166,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00167,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00168,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00169,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00170,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00171,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00173,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00175,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00176,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00177,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00178,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00179,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00180,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00181,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00182,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00183,AMR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AMR_00184,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00185,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00186,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00188,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00189,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00190,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00191,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00192,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00193,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00194,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00195,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00196,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00197,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00198,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00199,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00200,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_00201,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00202,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00203,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00204,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00205,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00206,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00207,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00209,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00210,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00211,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00212,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00213,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00214,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AMR_00215,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00216,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00217,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00218,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00219,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00221,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00223,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00224,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00225,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00227,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00229,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00231,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00232,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00233,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00235,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00236,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00237,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00238,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00240,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00241,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00243,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00245,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00246,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00247,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00248,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00249,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00250,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00251,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00252,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00253,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00254,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00255,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00256,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00259,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00261,AMR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00263,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00264,AMR,2,SOD1,7.0,Moderate,Fast Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00265,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00267,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00268,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00269,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00270,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00271,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00272,AMR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00273,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00274,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00275,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00276,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00277,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00278,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00279,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00280,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00281,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00283,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00284,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00285,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00287,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00288,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00289,AMR,3,OPTN,9.2,Severe,Fast Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_00290,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00291,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00292,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00293,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00295,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00296,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00298,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00299,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00301,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00303,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00304,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00305,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00306,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00307,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00308,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00309,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00310,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00312,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00313,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00314,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00315,AMR,3,SQSTM1,9.2,Severe,Fast Progression,SOD1; SPG11; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00316,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00318,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00319,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00320,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00321,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00322,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00324,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00325,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00326,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00327,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00328,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00329,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00330,AMR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00331,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00333,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00334,AMR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00335,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00336,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00337,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00338,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00339,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00340,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00341,AMR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00343,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00344,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00345,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00346,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00347,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00348,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00351,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00352,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00353,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AMR_00354,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00356,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00357,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00359,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00360,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00361,AMR,2,SOD1,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00362,AMR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00363,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00365,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00366,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00367,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00368,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00369,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00370,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00371,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00372,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00373,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00374,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00375,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00376,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00377,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00378,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00379,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00380,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00382,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00383,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00384,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00385,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00386,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00387,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00390,AMR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00391,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00392,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00393,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00394,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00396,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00397,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00398,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00399,AMR,2,TARDBP,7.0,Moderate,Slow Progression,CHRNA3; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00401,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00402,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00403,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00404,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00405,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00409,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00410,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00412,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00413,AMR,3,FIG4,9.2,Severe,Fast Progression,FIG4; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AMR_00414,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00417,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00419,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00420,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00421,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00422,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00423,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00424,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00426,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00427,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00428,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00429,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AMR_00430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00431,AMR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00433,AMR,2,LOC130056973,8.4,Severe,Fast Progression,LOC130056973; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AMR_00434,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00435,AMR,3,LOC124629354,8.4,Severe,Fast Progression,ALS2; FIG4; LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Unknown mechanism
AMR_00436,AMR,1,SIGMAR1,7.2,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00437,AMR,3,SPG11,7.0,Moderate,Slow Progression,HNRNPA1; SIGMAR1; SPG11,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,HNRNPA1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00438,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00439,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00440,AMR,1,DCTN1,7.7,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00441,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00442,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00445,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00446,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00448,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00450,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00451,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00452,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00453,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00454,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00455,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00457,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00458,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00460,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00461,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00462,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00463,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00464,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00465,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00466,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00467,AMR,3,TBK1,9.1,Severe,Fast Progression,SOD1; SQSTM1; TBK1,1,3,SOD1; SQSTM1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00468,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00469,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00470,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00472,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00473,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00474,AMR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00475,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00476,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_00477,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00479,AMR,2,TBK1,9.8,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00480,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00481,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00482,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00483,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00484,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00485,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00486,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00487,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AMR_00488,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00489,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00491,AMR,3,TBK1,7.7,Moderate,Slow Progression,ALS2; SPTLC1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00492,AMR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00493,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00494,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00495,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00496,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00498,AMR,2,SQSTM1,7.8,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00499,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00500,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00501,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00503,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00506,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00507,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00508,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00509,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00513,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00516,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00517,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00518,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00519,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00520,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00522,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00523,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00524,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00527,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00528,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00529,AMR,3,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AMR_00530,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AMR_00531,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00532,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00534,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00535,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00536,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00537,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00538,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00539,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00541,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00542,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00543,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00544,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00545,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00546,AMR,2,TBK1,7.7,Moderate,Slow Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00549,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00550,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00551,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00552,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_00553,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00555,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00556,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00557,AMR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00558,AMR,2,TARDBP,7.0,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00559,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00561,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00562,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00563,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00564,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00565,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00566,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00567,AMR,2,SPG11,7.0,Moderate,Fast Progression,PLEKHG5; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00568,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00569,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00570,AMR,1,TARDBP,7.0,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00571,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00572,AMR,3,TBK1,10.0,Severe,Fast Progression,PLEKHG5; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00573,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00575,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00576,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00577,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00578,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00579,AMR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00581,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00582,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00583,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00584,AMR,3,VCP,7.0,Moderate,Slow Progression,ALS2; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00586,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00588,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00589,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00590,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00591,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00592,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00594,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00595,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00597,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00598,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00599,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00600,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00601,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00602,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00603,AMR,2,TBK1,10.0,Severe,Fast Progression,C9orf72; TBK1,1,2,C9ORF72; TBK1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00605,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00606,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00607,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00608,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00609,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00611,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00612,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00614,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00615,AMR,2,FUS,9.0,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00616,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00617,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00618,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00619,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00620,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00621,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00622,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00625,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00627,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00628,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00629,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00630,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00631,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00632,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00633,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00634,AMR,2,LOC130001681,8.4,Severe,Fast Progression,ALS2; LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_00635,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00636,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00637,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00638,AMR,2,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00639,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00640,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00642,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00643,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00644,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00645,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00646,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00647,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00649,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00650,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00651,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00652,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00653,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00654,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00655,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00656,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00657,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00658,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00659,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00661,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00662,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00663,AMR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00664,AMR,2,SOD1,7.0,Moderate,Fast Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00665,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00667,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00668,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00669,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00670,AMR,2,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00671,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00672,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00673,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00676,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00677,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00679,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00680,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00681,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00682,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00684,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00685,AMR,2,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_00686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00687,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00690,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00692,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00693,AMR,3,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00694,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00695,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00696,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00697,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00698,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00699,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00700,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00701,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00702,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00704,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00707,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00708,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00710,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00711,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00712,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00713,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00714,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00715,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00717,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00718,AMR,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00719,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00721,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00722,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00724,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00725,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00727,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00728,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00729,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00730,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00731,AMR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00732,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00733,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00734,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00736,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00737,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00738,AMR,2,SOD1,7.0,Moderate,Slow Progression,PARK7; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00739,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00740,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00741,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00742,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00744,AMR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_00745,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00747,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00748,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00749,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00750,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00751,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_00752,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00753,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00754,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00755,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00756,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00757,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00759,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00760,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00764,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00765,AMR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00767,AMR,2,SPG11,7.0,Moderate,Slow Progression,ANG; SPG11,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,RNA_Metabolism,ANG: Ribosomal biogenesis impairment | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00768,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00769,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00770,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00772,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00773,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00775,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00776,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00777,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00779,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00780,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00782,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00784,AMR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00785,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00786,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00787,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00788,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00789,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00790,AMR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00791,AMR,3,SQSTM1,8.6,Severe,Fast Progression,SETX; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00792,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00793,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00795,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00796,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00797,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00798,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00799,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00800,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00801,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00802,AMR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00803,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00804,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00806,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00807,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00808,AMR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00809,AMR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00811,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; UNC13A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction
AMR_00812,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00813,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00814,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00815,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00816,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00817,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00818,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00819,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00820,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00821,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00823,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00824,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00825,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00826,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00828,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00829,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00830,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00832,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00835,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00836,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00837,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00838,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00839,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00841,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00842,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00843,AMR,2,VCP,7.7,Moderate,Slow Progression,KIF5A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00844,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00845,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00846,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00847,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00849,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00850,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00851,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00852,AMR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00853,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00854,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00856,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00857,AMR,2,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_00858,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00859,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00861,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00862,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00864,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00865,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00866,AMR,3,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00868,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00871,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00872,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00873,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00875,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00876,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00877,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00878,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00879,AMR,3,SOD1,7.7,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00880,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00881,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00882,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00883,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00884,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00885,AMR,1,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00888,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00889,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00891,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00892,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00895,AMR,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00896,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00897,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00898,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00899,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00900,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00901,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00902,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00903,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00904,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00905,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00906,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00908,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00909,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00910,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AMR_00911,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00912,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00913,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00915,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,DCTN1; LOC129995449,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Unknown mechanism
AMR_00916,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00917,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00918,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_00919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00920,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00922,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00923,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00924,AMR,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00925,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00927,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00928,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00929,AMR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00930,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00931,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00932,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00933,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00934,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00936,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00937,AMR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AMR_00938,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00939,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00940,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00942,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00943,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00944,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00945,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00946,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00947,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00948,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00949,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00950,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00951,AMR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00952,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00953,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00954,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00955,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,Endosome-lysosome fusion failure
AMR_00956,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AMR_00957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00958,AMR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00959,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00960,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00963,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00965,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00966,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00967,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00968,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00969,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00970,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_00971,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00972,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00973,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00974,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00975,AMR,2,OPTN,7.8,Moderate,Fast Progression,HNRNPA1; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00976,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00977,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00978,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00980,AMR,2,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1; TUBA4A,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation | TUBA4A: Microtubule destabilization,Stress granule dysregulation
AMR_00981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00982,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00983,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00986,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00987,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00988,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00989,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00990,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00991,AMR,2,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00993,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00996,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00997,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00998,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00999,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01000,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01001,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01002,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01004,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01005,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01007,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01009,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01010,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01011,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01012,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01013,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01014,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01015,AMR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01018,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01020,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01021,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01023,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01024,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01025,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01026,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01027,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01028,AMR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AMR_01029,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01030,AMR,1,KIF5A,7.8,Moderate,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01031,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01032,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01033,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01034,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01035,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01036,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01038,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01039,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01040,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01041,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01042,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01043,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01044,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01045,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01046,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01047,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01048,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01049,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01050,AMR,3,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_01051,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01052,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01053,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01054,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01056,AMR,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01057,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01058,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01059,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01060,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01061,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01062,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01063,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01064,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01065,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01066,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01069,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01070,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01071,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01072,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01073,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01074,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01076,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01077,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01078,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01079,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01080,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01081,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01082,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01083,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01085,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01086,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01087,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01088,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01089,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01090,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01091,AMR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01093,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01094,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01096,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01097,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01098,AMR,3,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AMR_01099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01100,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01101,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01102,AMR,2,SOD1,7.0,Moderate,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01104,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01106,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01107,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01108,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01109,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01110,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01111,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01112,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01113,AMR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01114,AMR,2,TBK1,9.1,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01115,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01116,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01118,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01119,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01120,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01121,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_01122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01123,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01124,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01125,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01127,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01128,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01129,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01130,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01131,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01132,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01133,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01134,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01135,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01136,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01139,AMR,4,TBK1,9.8,Severe,Fast Progression,ALS2; SETX; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01140,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01141,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01142,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01143,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01145,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01146,AMR,2,FUS,9.9,Severe,Slow Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01147,AMR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01148,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01149,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01150,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01151,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01153,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01154,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01155,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01156,AMR,3,SOD1,7.7,Moderate,Fast Progression,KIF5A; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01157,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01158,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01160,AMR,2,SPTLC1,6.9,Moderate,Slow Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_01161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01163,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01166,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01167,AMR,3,TBK1,10.0,Severe,Fast Progression,SIGMAR1; SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01168,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01169,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01170,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01171,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_01172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01173,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01175,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01176,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01177,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01178,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01179,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01180,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01181,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01182,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01183,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01184,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01185,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01186,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01188,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01189,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01190,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01191,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01192,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01193,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01194,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01195,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01196,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01197,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01198,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01199,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01200,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01201,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01202,AMR,3,TBK1,10.0,Severe,Fast Progression,ALS2; OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01203,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01204,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01205,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01206,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01207,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01209,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01210,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01211,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01212,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01213,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01214,AMR,2,KIF5A,6.6,Moderate,Slow Progression,ALS2; KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01215,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01216,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01217,AMR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01218,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01219,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01221,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01223,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01224,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01225,AMR,2,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01227,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01229,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01231,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01232,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01233,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01235,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01236,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01237,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01238,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01240,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01241,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01243,AMR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01245,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01246,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01247,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01248,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01249,AMR,2,TBK1,10.0,Severe,Fast Progression,LOC108903148; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01250,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01251,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01252,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01253,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01254,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01255,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01256,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01259,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01261,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01263,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01264,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01265,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01267,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Mitochondrial,SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation,R-loop accumulation; genomic instability
AMR_01268,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01269,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01270,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01271,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01272,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01273,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01274,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01275,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01276,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01277,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01278,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01279,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01280,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01281,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01283,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01284,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01285,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01287,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01288,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01289,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01290,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01291,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01292,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01293,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01295,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01296,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01298,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01299,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01301,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01303,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01304,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01305,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01306,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01307,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01308,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01309,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01310,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01312,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01313,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01314,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01315,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01316,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01318,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01319,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01320,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01321,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01322,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01324,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01325,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01326,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01327,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01328,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01329,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01330,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01331,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01333,AMR,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01334,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01335,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01336,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01337,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01338,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01339,AMR,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01340,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01341,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01343,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01344,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01345,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01346,AMR,1,SQSTM1,7.8,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01347,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01348,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01351,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01352,AMR,1,NEK1,7.8,Moderate,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_01353,AMR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01354,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01356,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01357,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01359,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01360,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01361,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01362,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01363,AMR,2,UNC13A,6.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01365,AMR,3,SPG11,7.0,Moderate,Fast Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01366,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01367,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01368,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01369,AMR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01370,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01371,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01372,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01373,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01374,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01375,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01376,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01377,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01378,AMR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01379,AMR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01380,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01382,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01383,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01384,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01385,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01386,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01387,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01390,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01391,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01392,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01393,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01394,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01396,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01397,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01398,AMR,2,SOD1,7.7,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01399,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01401,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01402,AMR,2,TBK1,7.7,Moderate,Slow Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_01403,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01404,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01405,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01409,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01410,AMR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01412,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; TUBA4A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | TUBA4A: Microtubule destabilization,Autophagy initiation kinase deficiency
AMR_01413,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01414,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01417,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01419,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01420,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01421,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01422,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01423,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01424,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01426,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01427,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01428,AMR,2,UBQLN2,7.7,Moderate,Fast Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01429,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01431,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01433,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01434,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01435,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01436,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01437,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01438,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01439,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01440,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01441,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
AMR_01442,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01445,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01446,AMR,2,C9orf72,8.8,Severe,Fast Progression,C9orf72; SPG11,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01448,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01450,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01451,AMR,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01452,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01453,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01454,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01455,AMR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01457,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01458,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01460,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01461,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01462,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01463,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01464,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01465,AMR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01466,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01467,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01468,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01469,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01470,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01472,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01473,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01474,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01475,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01476,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01477,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01479,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01480,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01481,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01482,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01483,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01484,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01485,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01486,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01487,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01488,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01489,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01491,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01492,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01493,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01494,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01495,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01496,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01498,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01499,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01500,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01501,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01503,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01506,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01507,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01508,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01509,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01513,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01516,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01517,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01518,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01519,AMR,2,UBQLN2,7.7,Moderate,Slow Progression,PLEKHG5; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01520,AMR,2,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01522,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01523,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01524,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01527,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01528,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01529,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01530,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01531,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,R-loop accumulation; genomic instability
AMR_01532,AMR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_01533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01534,AMR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01535,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01536,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01537,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01538,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01539,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01541,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01542,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01543,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01544,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01545,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01546,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01549,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01550,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01551,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01552,AMR,3,TBK1,10.0,Severe,Fast Progression,SOD1; SPG11; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01553,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01555,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01556,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01557,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01558,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01559,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01561,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01562,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01563,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01564,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01565,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01566,AMR,1,SIGMAR1,7.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01567,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01568,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01569,AMR,4,OPTN,9.2,Severe,Fast Progression,OPTN; SLC52A3; SPG11; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_01570,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01571,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01572,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01573,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01575,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01576,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01577,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01578,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01579,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01581,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01582,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01583,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01584,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01586,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01588,AMR,2,SOD1,7.7,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01589,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01590,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01591,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01592,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01594,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01595,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01597,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01598,AMR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosomal biogenesis failure
AMR_01599,AMR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01600,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01601,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01602,AMR,3,UBQLN2,7.7,Moderate,Fast Progression,ALS2; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01603,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01605,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01606,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01607,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01608,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01609,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01611,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01612,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01614,AMR,3,FUS,9.9,Severe,Fast Progression,FUS; SIGMAR1; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01615,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01616,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01617,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01618,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01619,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01620,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01621,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01622,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01625,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01627,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01628,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01629,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01630,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01631,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01632,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01633,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01634,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01635,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_01636,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01637,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01638,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01639,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01640,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01642,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01643,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01644,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_01645,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01646,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01647,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01649,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01650,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01651,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01652,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01653,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01654,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01655,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01656,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01657,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01658,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01659,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01661,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_01662,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01663,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01664,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01665,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01667,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01668,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01669,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01670,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01671,AMR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01672,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01673,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01676,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01677,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01679,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01680,AMR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Lysosomal biogenesis failure
AMR_01681,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01682,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01684,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01685,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01687,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01690,AMR,3,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1; TARDBP,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_01691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01692,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01693,AMR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01694,AMR,4,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148; SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,5,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Unknown mechanism
AMR_01695,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01696,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01697,AMR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01698,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01699,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01700,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01701,AMR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01702,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01704,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01707,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01708,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01710,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01711,AMR,2,SLC52A3,8.4,Severe,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_01712,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01713,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01714,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01715,AMR,2,SETX,5.2,Mild,Slow Progression,ERBB4; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01717,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01718,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01719,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01721,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01722,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01724,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01725,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01727,AMR,1,PLEKHG5,6.2,Moderate,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01728,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01729,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01730,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01731,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01732,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01733,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01734,AMR,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01736,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01737,AMR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01738,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01739,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01740,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01741,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01742,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01744,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01745,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01747,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01748,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01749,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01750,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01751,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01752,AMR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01753,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01754,AMR,2,SPG11,7.0,Moderate,Slow Progression,C9orf72; SPG11,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01755,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01756,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01757,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01759,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01760,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01764,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01765,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01767,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_01768,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01769,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01770,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01772,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01773,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01775,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01776,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01777,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01779,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01780,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01782,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01784,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01785,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01786,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01787,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01788,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01789,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01790,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01791,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01792,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_01793,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01795,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01796,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01797,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01798,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01799,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01800,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01801,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01802,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01803,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01804,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01806,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01807,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01808,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01809,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01811,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01812,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01813,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01814,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01815,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01816,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01817,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01818,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01819,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01820,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01821,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01823,AMR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01824,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01825,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01826,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01828,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01829,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01830,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01832,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01835,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01836,AMR,2,TBK1,10.0,Severe,Fast Progression,ANXA11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01837,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01838,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01839,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01841,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_01842,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01843,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01844,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01845,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01846,AMR,1,SETX,5.7,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01847,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01849,AMR,2,SOD1,7.0,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01850,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01851,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01852,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01853,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01854,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01856,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01857,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01858,AMR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01859,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01861,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01862,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01864,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01865,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01866,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01868,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01871,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01872,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01873,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_01874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01875,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01876,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01877,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01878,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01879,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01880,AMR,2,SQSTM1,8.4,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
AMR_01881,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01882,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01883,AMR,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AMR_01884,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01885,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01888,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01889,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01891,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01892,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01895,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01896,AMR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01897,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01898,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01899,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01900,AMR,2,TBK1,9.8,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01901,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01902,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01903,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01904,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01905,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01906,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01908,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01909,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01910,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01911,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01912,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01913,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01915,AMR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Unknown mechanism
AMR_01916,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01917,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01918,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01920,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01922,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01923,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01924,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01925,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01927,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01928,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01929,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01930,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01931,AMR,2,TBK1,9.8,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01932,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01933,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01934,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01936,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01937,AMR,2,VCP,7.0,Moderate,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01938,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01939,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01940,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01942,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_01943,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01944,AMR,3,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01945,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01946,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01947,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01948,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01949,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01950,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01951,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01952,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01953,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01954,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01955,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01956,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01958,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01959,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01960,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01963,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01965,AMR,3,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01966,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01967,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01968,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01969,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01970,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01971,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01972,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01973,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01974,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01975,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01976,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01977,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01978,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01980,AMR,2,VCP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01982,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01983,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01986,AMR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01987,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01988,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01989,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01990,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01991,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01993,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01996,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01997,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01998,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01999,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02000,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02001,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02002,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02004,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02005,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02007,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02009,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02010,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_02011,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02012,AMR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02013,AMR,1,SQSTM1,6.6,Moderate,Asymptomatic/Low Penetrance,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02014,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02015,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02018,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02020,AMR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02021,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02023,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02024,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02025,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02026,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02027,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02028,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02029,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02030,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02031,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02032,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02033,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02034,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02035,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02036,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02038,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02039,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02040,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02041,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02042,AMR,2,TBK1,10.0,Severe,Fast Progression,DCTN1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02043,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02044,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02045,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AMR_02046,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02047,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02048,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02049,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02050,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02051,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02052,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02053,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02054,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02056,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02057,AMR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02058,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02059,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02060,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02061,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02062,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02063,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02064,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02065,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02066,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02069,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02070,AMR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02071,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02072,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02073,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02074,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02076,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02077,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02078,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02079,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02080,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02081,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02082,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02083,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02085,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02086,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02087,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02088,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02089,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02090,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02091,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02093,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02094,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02096,AMR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02097,AMR,2,DCTN1,9.1,Severe,Fast Progression,DCTN1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Retrograde transport failure
AMR_02098,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02100,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02101,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02102,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02104,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02106,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02107,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02108,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02109,AMR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02110,AMR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02111,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02112,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02113,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02114,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02115,AMR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_02116,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AMR_02117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02118,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02119,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02120,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02121,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02123,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AMR_02124,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02125,AMR,3,OPTN,9.2,Severe,Fast Progression,OPTN; SLC52A3; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AMR_02126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02127,AMR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02128,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02129,AMR,3,SPG11,7.0,Moderate,Slow Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02130,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02131,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02132,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02133,AMR,3,FUS,10.0,Severe,Fast Progression,FIG4; FUS; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02134,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02135,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02136,AMR,3,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02139,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02140,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02141,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02142,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02143,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02145,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02146,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02147,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02148,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02149,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02150,AMR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02151,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02153,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02154,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02155,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02156,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02157,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02158,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02160,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02163,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02166,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02167,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02168,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02169,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02170,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02171,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02173,AMR,2,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02175,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02176,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02177,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02178,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02179,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02180,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02181,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02182,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02183,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02184,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02185,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02186,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02188,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
AMR_02189,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02190,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02191,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_02192,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02193,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02194,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02195,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AMR_02196,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02197,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02198,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02199,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02200,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02201,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02202,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02203,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02204,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02205,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02206,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02207,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02209,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02210,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02211,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02212,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02213,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02214,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02215,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02216,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02217,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02218,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02219,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02221,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02223,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02224,AMR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02225,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02227,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02229,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02231,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02232,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02233,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02235,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02236,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02237,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02238,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02240,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02241,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02243,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02245,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02246,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02247,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02248,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02249,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02250,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02251,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02252,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02253,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02254,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02255,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02256,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02259,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02261,AMR,2,SPG11,6.5,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02263,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02264,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02265,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02267,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02268,AMR,5,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02269,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02270,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02271,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02272,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02273,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02274,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02275,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02276,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02277,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02278,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02279,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02280,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02281,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02283,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02284,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02285,AMR,2,SOD1,7.7,Moderate,Slow Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02287,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02288,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02289,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02290,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02291,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02292,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02293,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02295,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,KIF5A; LOC129995449,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Unknown mechanism
AMR_02296,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02298,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02299,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02301,AMR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02303,AMR,2,SOD1,7.7,Moderate,Fast Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02304,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02305,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02306,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02307,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02308,AMR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02309,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02310,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02312,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02313,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02314,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02315,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02316,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02318,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02319,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02320,AMR,4,FIG4,7.8,Moderate,Fast Progression,FIG4; FUS; PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,5,Mitochondrial,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AMR_02321,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02322,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02324,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02325,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02326,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02327,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02328,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02329,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02330,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02331,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02333,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02334,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02335,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02336,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02337,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02338,AMR,3,OPTN,6.6,Moderate,Slow Progression,HNRNPA1; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02339,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02340,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02341,AMR,1,KIF5A,7.8,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_02342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02343,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02344,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02345,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02346,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02347,AMR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02348,AMR,2,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02351,AMR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02352,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02353,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02354,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02356,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02357,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02359,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02360,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02361,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02362,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02363,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02365,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02366,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02367,AMR,4,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN; SETX; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02368,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02369,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02370,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02371,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02372,AMR,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02373,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02374,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02375,AMR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02376,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02377,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02378,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02379,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02380,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02382,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02383,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02384,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02385,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02386,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02387,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02390,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02391,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02392,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02393,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02394,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02396,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02397,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02398,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02399,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02401,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02402,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02403,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02404,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02405,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02409,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02410,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02412,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02413,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02414,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02417,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02419,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02420,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02421,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02422,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02423,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02424,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02426,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02427,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02428,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02429,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02431,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02433,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02434,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02435,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02436,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02437,AMR,2,UNC13A,6.0,Moderate,Slow Progression,SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02438,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02439,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02440,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02441,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02442,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02445,AMR,1,LOC108903148,9.2,Severe,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02446,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02448,AMR,1,TBK1,7.0,Moderate,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02450,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02451,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02452,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02453,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02454,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02455,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02457,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02458,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02460,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02461,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02462,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02463,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02464,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02465,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02466,AMR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02467,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AMR_02468,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02469,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02470,AMR,2,LOC108903148,9.2,Severe,Fast Progression,HNRNPA2B1; LOC108903148,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Unknown mechanism
AMR_02471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02472,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02473,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02474,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02475,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02476,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02477,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02479,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02480,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02481,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02482,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02483,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02484,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02485,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02486,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02487,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02488,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02489,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02491,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02492,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02493,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02494,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02495,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02496,AMR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02498,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02499,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02500,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02501,AMR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02503,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02506,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02507,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02508,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02509,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02513,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02516,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02517,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AMR_02518,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02519,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02520,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02522,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02523,AMR,2,SPG11,7.7,Moderate,Fast Progression,SPG11; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,Lysosome reformation failure; DNA repair defects
AMR_02524,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,Endosome-lysosome fusion failure
AMR_02525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02527,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02528,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02529,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02530,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02531,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02532,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02534,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02535,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02536,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02537,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02538,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02539,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02541,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Endosome-lysosome fusion failure
AMR_02542,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02543,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02544,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02545,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02546,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02549,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02550,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02551,AMR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02552,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02553,AMR,2,TARDBP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02555,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02556,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02557,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02558,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02559,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02561,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02562,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02563,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02564,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02565,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02566,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,NEK1: DNA damage checkpoint failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,DNA damage checkpoint failure
AMR_02567,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02568,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02569,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02570,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02571,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02572,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02573,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02575,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02576,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02577,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02578,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02579,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02581,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02582,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02583,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02584,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02586,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02588,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02589,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02590,AMR,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02591,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02592,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02594,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02595,AMR,2,SOD1,9.8,Severe,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02597,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02598,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02599,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02600,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02601,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02602,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02603,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02605,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02606,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_02607,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02608,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02609,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02611,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02612,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02614,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02615,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02616,AMR,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AMR_02617,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02618,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02619,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02620,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02621,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02622,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02625,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02627,AMR,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02628,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02629,AMR,1,ANG,6.0,Moderate,Asymptomatic/Low Penetrance,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AMR_02630,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02631,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02632,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02633,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02634,AMR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02635,AMR,2,ALS2,7.0,Moderate,Fast Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AMR_02636,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02637,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02638,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02639,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02640,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02642,AMR,3,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Retrograde transport failure
AMR_02643,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02644,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02645,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02646,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02647,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02649,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02650,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02651,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02652,AMR,2,DCTN1,7.0,Moderate,Slow Progression,DCTN1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Retrograde transport failure
AMR_02653,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02654,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02655,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02656,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02657,AMR,1,OPTN,9.2,Severe,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02658,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02659,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02661,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02662,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02663,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02664,AMR,2,TBK1,9.8,Severe,Fast Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02665,AMR,3,SOD1,7.0,Moderate,Slow Progression,PARK7; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02667,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02668,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02669,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02670,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02671,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02672,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02673,AMR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
AMR_02674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02676,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02677,AMR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02679,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02680,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02681,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02682,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AMR_02683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02684,AMR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02685,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02687,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02690,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02692,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02693,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02694,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02695,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02696,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02697,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02698,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02699,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02700,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02701,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02702,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02704,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02707,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02708,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02710,AMR,1,CHRNA3,6.0,Moderate,Asymptomatic/Low Penetrance,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02711,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02712,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02713,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02714,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02715,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02717,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02718,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02719,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02721,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02722,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02724,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02725,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02727,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02728,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02729,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02730,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02731,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02732,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02733,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02734,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02736,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02737,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02738,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02739,AMR,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02740,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02741,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02742,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02744,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02745,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02747,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02748,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_02749,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02750,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02751,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02752,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02753,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02754,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02755,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02756,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02757,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02759,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02760,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02764,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02765,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02767,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02768,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02769,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02770,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02772,AMR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Retrograde transport failure
AMR_02773,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02775,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02776,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02777,AMR,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02779,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02780,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02782,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02784,AMR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02785,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02786,AMR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02787,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_02788,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02789,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02790,AMR,2,SQSTM1,7.8,Moderate,Fast Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02791,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02792,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02793,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02795,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02796,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02797,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02798,AMR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02799,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02800,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02801,AMR,2,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AMR_02802,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02803,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02804,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02806,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02807,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02808,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02809,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02811,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02812,AMR,2,KIF5A,7.8,Moderate,Fast Progression,KIF5A; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,KIF5A: Anterograde transport failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Anterograde transport failure
AMR_02813,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02814,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02815,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02816,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02817,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02818,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02819,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02820,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02821,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02823,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02824,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02825,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02826,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02828,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02829,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02830,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02832,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02835,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02836,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02837,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02838,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02839,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02841,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02842,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02843,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02844,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02845,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02846,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02847,AMR,2,TBK1,9.8,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02849,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02850,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02851,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02852,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02853,AMR,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02854,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02856,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02857,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02858,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02859,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02861,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02862,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02864,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02865,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02866,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02868,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02871,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02872,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02873,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02875,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02876,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02877,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02878,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02879,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02880,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02881,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02882,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02883,AMR,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02884,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02885,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02888,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02889,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02891,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02892,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02895,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02896,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02897,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02898,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02899,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02900,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02901,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02902,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02903,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02904,AMR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02905,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02906,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02908,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02909,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02910,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02911,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02912,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AMR_02913,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02915,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02916,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02917,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02918,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02920,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02922,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02923,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02924,AMR,1,TUBA4A,6.0,Moderate,Asymptomatic/Low Penetrance,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02925,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02927,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_02928,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02929,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02930,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02931,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02932,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02933,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02934,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02936,AMR,1,SCAF4,6.6,Moderate,Slow Progression,SCAF4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02937,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02938,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02939,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02940,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02942,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AMR_02943,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02944,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02945,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02946,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02947,AMR,2,SPG11,7.0,Moderate,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02948,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02949,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02950,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02951,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02952,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02953,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02954,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02955,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02956,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02958,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02959,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_02960,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02963,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02965,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02966,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02967,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02968,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02969,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02970,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02971,AMR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02972,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02973,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02974,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02975,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02976,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | HNRNPA2B1: Stress granule dysregulation,Endosome-lysosome fusion failure
AMR_02977,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02978,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02980,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02982,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02983,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02986,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02987,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02988,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02989,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02990,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02991,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02993,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02996,AMR,2,SOD1,7.0,Moderate,Slow Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02997,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02998,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02999,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
